DIM
ABBV icon

DLK Investment Management’s AbbVie ABBV Stock Holding History

DLK Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$509K Sell
1,946
-7
-0.4% -$1.79K 0.19% 55
2026
Q2 		$335K Buy
1,953
+7
+0.4% +$1.51K 0.14% 63
2026
Q1 		$423K Sell
1,946
-7
-0.4% -$1.55K 0.17% 53
2025
Q4 		$446K Hold
1,953
– – 0.17% 53
2025
Q3 		$452K Hold
1,953
– – 0.17% 51
2025
Q2 		$363K Hold
1,953
– – 0.14% 60
2025
Q1 		$409K Hold
1,953
– – 0.17% 50
2024
Q4 		$347K Hold
1,953
– – 0.15% 56
2024
Q3 		$386K Hold
1,953
– – 0.15% 63
2024
Q2 		$335K Hold
1,953
– – 0.14% 64
2024
Q1 		$356K Hold
1,953
– – 0.15% 61
2023
Q4 		$303K Buy
+1,953
New +$285K 0.14% 65

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

DLK Investment Management's ABBV Position: Q3 2026 in Review

DLK Investment Management reduced its AbbVie (ABBV) stake by 0.36% in Q3 2026, selling an estimated $1.79K and leaving 1,946 shares worth $509K. The position accounts for 0.19% of the portfolio, ranked #55.

DLK Investment Management first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • DLK Investment Management held 1,946 shares of AbbVie worth $509K as of Q3 2026.
  • DLK Investment Management sold 7 AbbVie shares in Q3 2026, an estimated $1.79K.
  • AbbVie made up 0.19% of DLK Investment Management's portfolio in Q3 2026, its #55 holding.
  • DLK Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on DLK Investment Management's 13F filing for Q3 2026, filed 9 Oct 2026.